A Pilot Study for Capacity Building for a Multi-centre, Randomized Trial for Treatment of Kala Azar in Bangladesh

NACompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

March 31, 2008

Study Completion Date

July 31, 2009

Conditions
Visceral Leishmaniasis
Interventions
DRUG

Randomized trial for treatment of kala azar in Bangladesh

dose of SAG 20 mg/kg body weight, with a maximum dose of 850 mg/day, for 28 days

Trial Locations (1)

Unknown

Community-based Medical College, Bangladesh (CBMC,B), Mymensingh

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Community Based Medical College, Bangladesh

OTHER

collaborator

Dhaka Medical College

OTHER

collaborator

Directorate General of Health Services of Bangladesh

UNKNOWN

lead

International Centre for Diarrhoeal Disease Research, Bangladesh

OTHER